Home » Middle East Venture Capital »


|| UAE investors of Crescent Enterprises invested $16 million in US MedTech firms

cres-us.jpgUAE-based corporate venture arm of Crescent Enterprises Ventures has invested $16 million in two American medtech firms ColubrisMX and XCath.

ColubrisMX is a Houston-based micro-robotic medical device enterprise. XCath is developing steerable robotic microcatheters which will be used in treating cerebral strokes and other endovascular conditions. (Launched in November 2017, Crescent Enterprises Ventures, or CE-V, is the corporate venture arm of Crescent Enterprises. The UAE-based company operates in sectors such as ports and logistics, power and engineering, business aviation and healthcare.) More details here.

Crescent Enterprises is listed in the Middle East Investors Directory with the code SIJ60.



Previous Post: VC arm of family office Almajdouie Holding invested $1.4 million in Trukker
Next Post: Dubai investors of ICD acquired 25% of Italian firm CAI

More from Middle East Venture Capital ...


  UAE investors of Crescent Enterprises invested $16 million in US MedTech firms

  Middle East investment firm EIP and consortium acquired UAE firm for $17 million

  Silicon Valley VC firm seeks Middle East investors for $100 million fund

  MENA Venture Investments acquired stake in Wysada.com

  Middle East Venture Partners invested in 3 new firms

  Link Online acquires web portal Arabia.com

  Middle East Venture Partners invested in 4 new firms

  HBT Ventures - a new tech investment firm in the Middle East

  Abu Dhabi firm invests $2.5 million in two online gaming firms

  Another startup incubator for the Middle East - now in Bahrain




|| About Us

Established in 2007, DubaiBeat.com provides insight, analysis and research on Middle East investors.

We cover different asset class investors like private equity, venture capital, hedge funds and real estate investors from the Middle East and broader MENA region.


|| Subscribe















Copyright 2007-2021 DubaiBeat.com    Sitemap  |  Terms  |  Privacy Policy

Follow us: RSS Feed   Facebook    Twitter